Showing 881-890 of 989 results for "".
- Evolus: Jeuveau FDA Cleared for Aesthetic Injectionhttps://modernaesthetics.com/news/evolus-jeuveau-fda-cleared-for-aesthetic-injection/2471954/The FDA has approved Jeuveau™ (prabotulinumtoxinA-xvfs), the lead product from Evolus, Inc., for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. It will be available to physicians this sp
- #RealDealAesthetics Tackles Minimally Invasive Body Contouringhttps://modernaesthetics.com/news/realdealaesthetics-tackles-minimally-invasive-body-contouring/2471964/Save the date: Modern Aesthetics’® newest Tweet chat series -- #RealDealAesthetics -- featuring New York City dermatologist Gary Goldenberg, MD and Charleston, SC dermatologist Todd E. Schlesinger, MD is back. The first Tweet chat of 2019 focuses on minimally in
- AAFPRS Members Look Into Their Crystal Balls for the Year Aheadhttps://modernaesthetics.com/news/aafprs-members-look-into-their-crystal-balls-for-the-year-ahead/2471970/Facial plastic surgeons are taking out their crystal balls to share a glimpse of what we will see more, or less of, in the coming year in cosmetic surgery. Natural-looking results are here to stay. Gone, but not totally forgotten are the highly sculpted nose
- Revance Shares Positive Efficacy and Duration Data for RT002https://modernaesthetics.com/news/revance-share-positive-efficacy-and-duration-data-for-rt002/2471986/Revance Therapeutics, Inc.'s long-acting neuromodulator daxibotulinumtoxinA for Injection (RT002) with its proprietary stabilizing excipient peptide technology delivered positive top-line results in alleviating moderate to severe glabellar lines in the SAKURA 3 Phase 3 open-label, long-term s
- Sinclair Pharma: Acquisition by Huadong Medicine Company Limited Now Completehttps://modernaesthetics.com/news/sinclair-pharma-acquisition-by-huadong-medicine-company-limited-now-complete/2471988/Huadong Medicine Company Limited (HMC) has acquired Sinclair Pharma Limited, a global aesthetics company headquartered in London, UK, in a deal worth approximately $222 million. HMC is a well-known Chinese pharmaceutical listed company that has established a leading aesthetics business in China a
- ISAPS 2017: US Still Reigns As Cosmetic Surgery Capitol of the Worldhttps://modernaesthetics.com/news/isaps-2017-us-still-reigns-as-cosmetic-surgery-capitol-of-the-world/2471994/The USA, Brazil, Japan, Italy and Mexico continue to perform the most cosmetic surgery procedures across the globe, according to the 2017 statistics from the International Society of Aesthetic Plastic Surgery (ISAPS). These top five countries account f
- xMedica Launches Aesthetics Conference Focused on Energy Based Treatments for Male and Female Sexual Wellnesshttps://modernaesthetics.com/news/xmedica-launches-aesthetics-conference-focused-on-energy-based-treatments-for-male-and-female-sexual-wellness/2472007/Medical education consortium xMedica LLC of Atlanta has developed a new educational initiative, "The Use of Energy-Based Devices for Improving Sexual Health." The overriding goal of this unique conference is to present factual data in a CME setting to address this new are
- ARTAS iX: Real-World Evaluation Study Shows Benefithttps://modernaesthetics.com/news/artas-ix-real-world-evaluation-study-shows-benefit/2472009/Restoration Robotics, Inc. (NASDAQ: HAIR), the global leader in robotic hair restoration, today announced results from a real-world evaluation study of The new ARTAS iX™ Robotic Hair Restoration System demonstrates clinical efficiency in hair harvesting and implan
- Nestle to Explore Strategic Options for Skin Health Divisionhttps://modernaesthetics.com/news/nestle-to-explore-strategic-options-for-skin-health-division/2472031/...After further analysis and consideration, the Board has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group’s strategic scope
- Thermi Debuts Arvati Platformhttps://modernaesthetics.com/news/themi-debuts-arvati-platform/2472041/Thermi, an Almirall company, is launching Arvati, a next-generation 510K US Food and Drug Administration-cleared, true temperature-controlled radiofrequen